{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:49:21Z","timestamp":1791308961533,"version":"4.3.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10096-009-0739-z","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T07:15:24Z","timestamp":1240816524000},"page":"881-891","source":"Crossref","is-referenced-by-count":91,"title":["The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target"],"prefix":"10.1007","volume":"28","author":[{"given":"K.","family":"Mazumdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Dastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. K.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"739_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/14750708.1.1.1","volume":"1","author":"A Ray","year":"2004","unstructured":"Ray A, Rice LB (2004) Wildcatters welcome: the need for new antimicrobial agents. Therapy 1:1\u20135. doi: 10.2217\/14750708.1.1.1","journal-title":"Therapy"},{"key":"739_CR2","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1046\/j.1365-2672.92.5s1.13.x","volume":"92","author":"I Chopra","year":"2002","unstructured":"Chopra L, Hesse L, O\u2019Neill AJ (2002) Exploiting current understanding of antibiotic action for discovery of new drugs. J Appl Microbiol 92:4S\u201315S. doi: 10.1046\/j.1365-2672.92.5s1.13.x","journal-title":"J Appl Microbiol"},{"issue":"Suppl 3","key":"739_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1469-0691.8.s.3.3.x","volume":"8","author":"R Finch","year":"2002","unstructured":"Finch R (2002) Bacterial resistance\u2014the clinical challenge. Clin Microbiol Infect 8(Suppl 3):21\u201332. doi: 10.1046\/j.1469-0691.8.s.3.3.x","journal-title":"Clin Microbiol Infect"},{"key":"739_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","volume":"1","author":"C Walsh","year":"2003","unstructured":"Walsh C (2003) Where will new antibiotics come from? Nat Rev Microbiol 1:65\u201370. doi: 10.1038\/nrmicro727","journal-title":"Nat Rev Microbiol"},{"key":"739_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.01033-06","volume":"51","author":"YY Chan","year":"2007","unstructured":"Chan YY, Ong YM, Chua KL (2007) Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother 51:623\u2013630. doi: 10.1128\/AAC.01033-06","journal-title":"Antimicrob Agents Chemother"},{"key":"739_CR6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dkm071","volume":"59","author":"JE Kristiansen","year":"2007","unstructured":"Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christensen JB, Flores VC, Keyzer H (2007) Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother 59:1271\u20131279. doi: 10.1093\/jac\/dkm071","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"739_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138945006777709584","volume":"7","author":"J Moln\u00e1r","year":"2006","unstructured":"Moln\u00e1r J (2006) The reversal of drug resistance from bacteria to cancer cells. Curr Drug Targets 7(7):789\u2013791. doi: 10.2174\/138945006777709584","journal-title":"Curr Drug Targets"},{"issue":"8","key":"739_CR8","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.49.8.3578-3582.2005","volume":"49","author":"M Viveiros","year":"2005","unstructured":"Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Moln\u00e1r AM, Moln\u00e1r J, Amaral L (2005) Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 49(8):3578\u20133582. doi: 10.1128\/AAC.49.8.3578-3582.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"739_CR9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","volume":"47","author":"GW Kaatz","year":"2003","unstructured":"Kaatz GW, Moudgal VV, Seo SM, Kristiansen JE (2003) Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 47(2):719\u2013726. doi: 10.1128\/AAC.47.2.719-726.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"739_CR10","first-page":"135","volume":"57","author":"JE Kristiansen","year":"1991","unstructured":"Kristiansen JE (1991) Antimicrobial activity of nonantibiotics. Am Soc Microbiol News 57(3):135\u2013139","journal-title":"Am Soc Microbiol News"},{"key":"739_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/40.3.319","volume":"40","author":"JE Kristiansen","year":"1997","unstructured":"Kristiansen JE, Amaral L (1997) The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 40:319\u2013327. doi: 10.1093\/jac\/40.3.319","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"739_CR12","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/AAC.35.9.1923","volume":"35","author":"L Amaral","year":"1991","unstructured":"Amaral L, Lorian V (1991) Effects of chlorpromazine on the cell envelope proteins of Escherichia coli. Antimicrob Agents Chemother 35(9):1923\u20131924","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"739_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","volume":"17","author":"M Viveiros","year":"2001","unstructured":"Viveiros M, Amaral L (2001) Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents 17(3):225\u2013228. doi: 10.1016\/S0924-8579(00)00343-5","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"739_CR14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2007.04.018","volume":"30","author":"NK Dutta","year":"2007","unstructured":"Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Moln\u00e1r J, Martins M, Amaral L (2007) Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. Int J Antimicrob Agents 30(3):242\u2013249. doi: 10.1016\/j.ijantimicag.2007.04.018","journal-title":"Int J Antimicrob Agents"},{"key":"739_CR15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jac\/dkl500","volume":"59","author":"L Amaral","year":"2007","unstructured":"Amaral L, Martins M, Viveiros M (2007) Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59:1237\u20131246. doi: 10.1093\/jac\/dkl500","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"739_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187152108783329807","volume":"7","author":"L Amaral","year":"2008","unstructured":"Amaral L, Martins M, Viveiros M (2008) Enhanced killing of intracellular pathogenic bacteria by phenothiazines and the role of K+ efflux pumps of the bacterium and the killing macrophage. Anti-Infective Agents Med Chem 7(1):63\u201372. doi: 10.2174\/187152108783329807","journal-title":"Anti-Infective Agents Med Chem"},{"key":"739_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2672.1976.tb00621.x","volume":"41","author":"SG Dastidar","year":"1976","unstructured":"Dastidar SG, Saha PK, Sanyamat B, Chakrabarty AN (1976) Antibacterial activity of ambodryl and benadryl. J Appl Bacteriol 41:209\u2013214","journal-title":"J Appl Bacteriol"},{"key":"739_CR18","first-page":"869","volume":"38","author":"D Chattopadhyay","year":"1998","unstructured":"Chattopadhyay D, Dastidar SG, Chakrabarty AN (1998) Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents. Arzneimittelforschung 38:869\u2013872","journal-title":"Arzneimittelforschung"},{"key":"739_CR19","first-page":"233","volume":"89","author":"AN Chakrabarty","year":"1989","unstructured":"Chakrabarty AN, Acharya DP, Neogi DK, Dastidar SG (1989) Drug interaction of promethazine & other some non-conventional antimicrobial chemotherapeutic agents. Indian J Med Res 89:233\u2013237","journal-title":"Indian J Med Res"},{"key":"739_CR20","first-page":"241","volume":"44","author":"SG Dastidar","year":"1997","unstructured":"Dastidar SG, Jairaj J, Mookerjee M, Chakrabarty AN (1997) Studies on antimicrobial effect of the antihistaminic phenothiazine trimeprazine tartrate. Acta Microbiol Immunol Hung 44:241\u2013247","journal-title":"Acta Microbiol Immunol Hung"},{"key":"739_CR21","first-page":"324","volume":"15","author":"SK Dash","year":"1977","unstructured":"Dash SK, Dastidar SG, Chakrabarty AN (1977) Antimicrobial activity of promazine hydrochloride. Indian J Exp Biol 15:324\u2013326","journal-title":"Indian J Exp Biol"},{"key":"739_CR22","first-page":"142","volume":"84","author":"SG Dastidar","year":"1986","unstructured":"Dastidar SG, Mondal U, Niyogi S, Chakrabarty AN (1986) Antibacterial property of methyl-DOPA and development of cross-resistance in m-DOPA mutants. Indian J Med Res 84:142\u2013147","journal-title":"Indian J Med Res"},{"key":"739_CR23","first-page":"539","volume":"19","author":"NK Dutta","year":"2005","unstructured":"Dutta NK, Mazumdar K, Dastidar SG, Chakrabarty AN, Shirataki Y, Motohashi N (2005) In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA. In Vivo 19:539\u2013545","journal-title":"In Vivo"},{"issue":"3","key":"739_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0255-0857(21)03067-X","volume":"21","author":"A Sarkar","year":"2003","unstructured":"Sarkar A, Kumar KA, Dutta NK, Chakraborty P, Dastidar SG (2003) Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochloride. Indian J Med Microbiol 21(3):172\u2013178","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"739_CR25","first-page":"285","volume":"52","author":"KA Kumar","year":"2003","unstructured":"Kumar KA, Ganguly K, Mazumdar K, Dutta NK, Dastidar SG, Chakrabarty AN (2003) Amlodipine: a cardiovascular drug with powerful antimicrobial property. Acta Microbiol Pol 52(3):285\u2013292","journal-title":"Acta Microbiol Pol"},{"key":"739_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1078\/0944-5013-00204","volume":"158","author":"K Mazumdar","year":"2003","unstructured":"Mazumdar K, Ganguly K, Kumar KA, Dutta NK, Chakrabarty AN, Dastidar SG (2003) Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride. Microbiol Res 158:259\u2013264. doi: 10.1078\/0944-5013-00204","journal-title":"Microbiol Res"},{"key":"739_CR27","unstructured":"Manna KK, Dastidar SG (1984) The anti-hypertensive drug propranolol hydrochloride (carditap): its anti-bacterial property. In: Proceedings of the 6th National Congress of the Indian Association of Medical Microbiologists (IAMM), pp 137-141"},{"key":"739_CR28","first-page":"192","volume":"118","author":"P Karak","year":"2003","unstructured":"Karak P, Kumar KA, Mazumdar K, Mookerjee M, Dastidar SG (2003) Antibacterial potential of an antispasmodic drug dicyclomine hydrochloride. Indian J Med Res 118:192\u2013196","journal-title":"Indian J Med Res"},{"issue":"12","key":"739_CR29","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1248\/bpb.27.2010","volume":"27","author":"P Karaka","year":"2004","unstructured":"Karaka P, Kumar KA, Basu LR, Dasgupta A, Ray R, Dastidar SG (2004) Experimental analysis of antimicrobial action of dicyclomine hydrochloride. Biol Pharm Bull 27(12):2010\u20132013. doi: 10.1248\/bpb.27.2010","journal-title":"Biol Pharm Bull"},{"key":"739_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1179\/joc.1995.7.3.201","volume":"7","author":"SG Dastidar","year":"1995","unstructured":"Dastidar SG, Chaudhury A, Annadurai S, Roy S, Mookerjee M, Chakrabarty AN (1995) In vitro and in vivo antimicrobial action of fluphenazine. J Chemother 7:201\u2013206","journal-title":"J Chemother"},{"key":"739_CR31","first-page":"671","volume":"37","author":"V Radhakrishnan","year":"1999","unstructured":"Radhakrishnan V, Ganguly K, Ganguly M, Dastidar SG, Chakrabarty AN (1999) Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent. Indian J Exp Biol 37:671\u2013675","journal-title":"Indian J Exp Biol"},{"key":"739_CR32","first-page":"40","volume":"30","author":"P Bourlioux","year":"1992","unstructured":"Bourlioux P, Moreaux JM, Su WJ, Boureau H (1992) In vitro antimicrobial activity of 18 phenothiazine derivatives: structure\u2013activity relationship. APMIS Suppl 30:40\u201343","journal-title":"APMIS Suppl"},{"key":"739_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2006.10.013","volume":"29","author":"M Martins","year":"2007","unstructured":"Martins M, Schelz Z, Martins A, Moln\u00e1r J, Haj\u00f6s G, Riedl Z, Viveiros M, Yalcin I, Aki-Sener E, Amaral L (2007) In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Int J Antimicrob Agents 29:338\u2013340. doi: 10.1016\/j.ijantimicag.2006.10.013","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"739_CR34","first-page":"771","volume":"21","author":"M Martins","year":"2007","unstructured":"Martins M, Viveiros M, Kristiansen JE, Moln\u00e1r J, Amaral L (2007) The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis. In Vivo 21(5):771\u2013775","journal-title":"In Vivo"},{"key":"739_CR35","first-page":"86","volume":"36","author":"S Annadurai","year":"1998","unstructured":"Annadurai S, Basu S, Ray S, Dastidar SG, Chakrabarty AN (1998) Antibacterial activity of the antiinflammatory agent diclofenac sodium. Indian J Exp Biol 36:86\u201390","journal-title":"Indian J Exp Biol"},{"issue":"4","key":"739_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10096-007-0439-5","volume":"27","author":"NK Dutta","year":"2008","unstructured":"Dutta NK, Mazumdar K, Baek MW, Kim DJ, Na YR, Park SH, Lee HK, Lee BH, Park JH (2008) In vitro efficacy of diclofenac against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 27(4):315\u2013319. doi: 10.1007\/s10096-007-0439-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"739_CR37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1472-765X.2008.02391.x","volume":"47","author":"NK Dutta","year":"2008","unstructured":"Dutta NK, Mazumdar K, Seok SH, Park JH (2008) The anti-inflammatory drug Diclofenac retains anti-listerial activity in vivo. Lett Appl Microbiol 47:106\u2013111. doi: 10.1111\/j.1472-765X.2008.02391.x","journal-title":"Lett Appl Microbiol"},{"issue":"42","key":"739_CR38","first-page":"5814","volume":"161","author":"AB Bender","year":"1999","unstructured":"Bender AB, Kristiansen JE (1999) Antimicrobial effects of anesthetics and analgesics. Ugeskr Laeger 161(42):5814\u20135817","journal-title":"Ugeskr Laeger"},{"key":"739_CR39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.52.4.490","volume":"52","author":"WH Wang","year":"2003","unstructured":"Wang WH, Wong WM, Dailidiene D, Berg DE, Gu Q, Lai KC, Lam SK, Wong BC (2003) Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 52:490\u2013495. doi: 10.1136\/gut.52.4.490","journal-title":"Gut"},{"key":"739_CR40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239036","volume":"38","author":"AJ Crowle","year":"1992","unstructured":"Crowle AJ, Douvas GS, May MH (1992) Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Chemotherapy 38:410\u2013419","journal-title":"Chemotherapy"},{"key":"739_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-3156.2005.01417.x","volume":"10","author":"M Wainwright","year":"2005","unstructured":"Wainwright M, Amaral L (2005) The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop Med Int Health 10:501\u2013511. doi: 10.1111\/j.1365-3156.2005.01417.x","journal-title":"Trop Med Int Health"},{"key":"739_CR42","first-page":"171","volume":"5","author":"D Chattopadhyay","year":"1987","unstructured":"Chattopadhyay D, Dastidar SG, Chakrabarty AN (1987) Determination of in vitro activity of methdilazine, an antihistamine, and its synergism with aminoglycoside antibiotics. Indian J Med Microbiol 5:171\u2013177","journal-title":"Indian J Med Microbiol"},{"key":"739_CR43","first-page":"253","volume":"28","author":"S Ray","year":"1990","unstructured":"Ray S, Chattopadhyay D, Dastidar SG, Chakrabarty AN (1990) Studies on synergism between penicillins and ambodryl (bromodiphenhydramine HCl), an antihistamine with antimicrobial property. Indian J Exp Biol 28:253\u2013258","journal-title":"Indian J Exp Biol"},{"issue":"1","key":"739_CR44","first-page":"41","volume":"41","author":"SG Dastidar","year":"1994","unstructured":"Dastidar SG, Chakraborty P, Mookerjee M, Ganguly M, Chakrabarty AN (1994) Studies on the existence of synergism between different antibiotics and a phenothiazine tranquilizer, promazine, possessing antimicrobial property. Acta Microbiol Immunol Hung 41(1):41\u201349","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"3","key":"739_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0924-8579(00)00131-X","volume":"14","author":"G Gunics","year":"2000","unstructured":"Gunics G, Motohashi N, Amaral L, Farkas S, Moln\u00e1r J (2000) Interaction between antibiotics and non-conventional antibiotics on bacteria. Int J Antimicrob Agents 14(3):239\u2013242. doi: 10.1016\/S0924-8579(00)00131-X","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"739_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02549770","volume":"22","author":"J Moln\u00e1r","year":"1990","unstructured":"Moln\u00e1r J, Haszon I, Bodrogi T, Martonyi E, Turi S (1990) Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis. Int J Urol Nephrol 22(5):405\u2013411. doi: 10.1007\/BF02549770","journal-title":"Int J Urol Nephrol"},{"key":"739_CR47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jac\/30.4.556","volume":"30","author":"L Amaral","year":"1992","unstructured":"Amaral L, Kristiansen JE, Lorian V (1992) Synergic effect of chlorpromazine on the activity of some antibiotics. J Antimicrob Chemother 30:556\u2013558. doi: 10.1093\/jac\/30.4.556","journal-title":"J Antimicrob Chemother"},{"key":"739_CR48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","volume":"17","author":"M Viveiros","year":"2001","unstructured":"Viveiros M, Amaral L (2001) Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents 17:225\u2013228. doi: 10.1016\/S0924-8579(00)00343-5","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"739_CR49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","volume":"30","author":"NK Dutta","year":"2007","unstructured":"Dutta NK, Mazumdar K, Dastidar SG, Park JH (2007) Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents 30(4):336\u2013340. doi: 10.1016\/j.ijantimicag.2007.04.016","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"739_CR50","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1248\/bpb.27.1116","volume":"27","author":"KA Kumar","year":"2004","unstructured":"Kumar KA, Mazumdar K, Dutta NK, Karak P, Dastidar SG, Ray R (2004) Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine. Biol Pharm Bull 27(7):1116\u20131120. doi: 10.1248\/bpb.27.1116","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"739_CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1248\/bpb.28.713","volume":"28","author":"K Mazumdar","year":"2005","unstructured":"Mazumdar K, Dutta NK, Kumar KA, Dastidar SG (2005) In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains. Biol Pharm Bull 28(4):713\u2013717. doi: 10.1248\/bpb.28.713","journal-title":"Biol Pharm Bull"},{"key":"739_CR52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0924-8579(99)00158-2","volume":"14","author":"AN Chakrabarty","year":"2000","unstructured":"Chakrabarty AN, Mookerjee M, Dastidar SG (2000) Screening for anti-HIV drugs that can combine virucidal and virustatic activities synergistically. Int J Antimicrob Agents 14:215\u2013220. doi: 10.1016\/S0924-8579(99)00158-2","journal-title":"Int J Antimicrob Agents"},{"key":"739_CR53","first-page":"21","volume":"47","author":"A Guha Thakurta","year":"2000","unstructured":"Guha Thakurta A, Mandal SK, Ganguly K, Dastidar SG, Chakrabarty AN (2000) A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine. Acta Microbiol Immunol Hung 47:21\u201328","journal-title":"Acta Microbiol Immunol Hung"},{"key":"739_CR54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.micres.2004.10.002","volume":"160","author":"L Rani Basu","year":"2005","unstructured":"Rani Basu L, Mazumdar K, Dutta NK, Karak P, Dastidar SG (2005) Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine. Microbiol Res 160:95\u2013100. doi: 10.1016\/j.micres.2004.10.002","journal-title":"Microbiol Res"},{"key":"739_CR55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/47.5.505","volume":"47","author":"L Amaral","year":"2001","unstructured":"Amaral L, Kristiansen JE, Viveiros M, Atouguia J (2001) Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. J Antimicrob Chemother 47:505\u2013511. doi: 10.1093\/jac\/47.5.505","journal-title":"J Antimicrob Chemother"},{"key":"739_CR56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0924-8579(99)00153-3","volume":"14","author":"L Amaral","year":"2000","unstructured":"Amaral L, Kristiansen JE (2000) Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies. Int J Antimicrob Agents 14:173\u2013176. doi: 10.1016\/S0924-8579(99)00153-3","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"739_CR57","first-page":"613","volume":"20","author":"K Mazumdar","year":"2006","unstructured":"Mazumdar K, Dutta NK, Dastidar SG, Motohashi N, Shirataki Y (2006) Diclofenac in the management of E. coli urinary tract infections. In Vivo 20(5):613\u2013619","journal-title":"In Vivo"},{"key":"739_CR58","first-page":"922","volume":"42","author":"NK Dutta","year":"2004","unstructured":"Dutta NK, Kumar KA, Mazumdar K, Dastidar SG (2004) In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium. Indian J Exp Biol 42:922\u2013927","journal-title":"Indian J Exp Biol"},{"key":"739_CR59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/S1517-83822004000300009","volume":"35","author":"NK Dutta","year":"2004","unstructured":"Dutta NK, Dastidar SG, Kumar A, Mazumdar K, Ray R, Chakrabarty AN (2004) Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin. Braz J Microbiol 35:316\u2013323. doi: 10.1590\/S1517-83822004000300009","journal-title":"Braz J Microbiol"},{"key":"739_CR60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0924-8579(99)00159-4","volume":"14","author":"SG Dastidar","year":"2000","unstructured":"Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN (2000) The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents 14:249\u2013251. doi: 10.1016\/S0924-8579(99)00159-4","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"739_CR61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1009246122577","volume":"12","author":"A Theodorou","year":"1999","unstructured":"Theodorou A, Demertzis MA, Kovala-Demertzi D, Lioliou EE, Pantazaki AA, Kyriakidis DA (1999) Copper(II) complexes of diclofenac: spectroscopic studies and DNA strand breakage. BioMetals 12(2):167\u2013172. doi: 10.1023\/A:1009246122577","journal-title":"BioMetals"},{"issue":"3","key":"739_CR62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1574-6968.1993.tb06337.x","volume":"110","author":"P Ratnakar","year":"1993","unstructured":"Ratnakar P, Murthy PS (1993) Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv. FEMS Microbiol Lett 110(3):291\u2013294. doi: 10.1111\/j.1574-6968.1993.tb06337.x","journal-title":"FEMS Microbiol Lett"},{"key":"739_CR63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jcpa.2003.10.001","volume":"130","author":"JH Park","year":"2004","unstructured":"Park JH, Park YH, Seok SH, Cho SA, Kim DJ, Lee HY, Kim SH, Park JH (2004) Suppurative gastritis in BALB\/c mice infected with Listeria monocytogenes via the intragastric route. J Comp Pathol 130:130\u2013136. doi: 10.1016\/j.jcpa.2003.10.001","journal-title":"J Comp Pathol"},{"key":"739_CR64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.micpath.2004.05.002","volume":"37","author":"JH Park","year":"2004","unstructured":"Park JH, Kim DJ, Park YH, Seok SH, Cho SA, Baek MW, Lee HY, Park JH (2004) Characteristics of the gastritis induced by Listeria monocytogenes in mice: microbiology, histopathology, and mRNA expression of inflammatory mediators with time course of infection. Microb Pathog 37:87\u201394. doi: 10.1016\/j.micpath.2004.05.002","journal-title":"Microb Pathog"},{"key":"739_CR65","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1099\/jmm.0.45918-0","volume":"54","author":"HY Lee","year":"2005","unstructured":"Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee BH, Kang PD, Kim YS, Park JH (2005) Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice. J Med Microbiol 54:1049\u20131054. doi: 10.1099\/jmm.0.45918-0","journal-title":"J Med Microbiol"},{"key":"739_CR66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tox.2004.03.010","volume":"200","author":"G Ravel","year":"2004","unstructured":"Ravel G, Christ M, Horand F, Descotes J (2004) Cytokine release does not improve the sensitivity and specificity of the direct popliteal lymph node assay. Toxicology 200:247\u2013254. doi: 10.1016\/j.tox.2004.03.010","journal-title":"Toxicology"},{"key":"739_CR67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/AAC.43.2.360","volume":"43","author":"C Sano","year":"1999","unstructured":"Sano C, Shimizu T, Sato K, Kawauchi H, Kawahara S, Tomioka H (1999) Therapeutic effects of benzoxazinorifamycin krm-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice. Antimicrob Agents Chemother 43:360\u2013364","journal-title":"Antimicrob Agents Chemother"},{"key":"739_CR68","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/cyto.1995.0047","volume":"7","author":"I Tsuboi","year":"1995","unstructured":"Tsuboi I, Tanaka H, Nakao M, Shichijo S, Itoh K (1995) Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production. Cytokine 7:372\u2013379. doi: 10.1006\/cyto.1995.0047","journal-title":"Cytokine"},{"key":"739_CR69","volume-title":"Nonsteroidal anti-inflammatory drugs: mechanisms and clinical use","author":"AJ Lewis","year":"1987","unstructured":"Lewis AJ, Furst DW (1987) Nonsteroidal anti-inflammatory drugs: mechanisms and clinical use. Marcel Dekker, New York"},{"key":"739_CR70","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.bmc.2005.12.042","volume":"14","author":"D Sriram","year":"2006","unstructured":"Sriram D, Yogeeswari P, Devakaram RV (2006) Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg Med Chem 14:3113\u20133118. doi: 10.1016\/j.bmc.2005.12.042","journal-title":"Bioorg Med Chem"},{"key":"739_CR71","unstructured":"Goodman GA (2001) NSAIDs. In: Hardman JH, Limbird LE, Goodman GA (eds) Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, 10th edn. . Vols I and II. McGraw-Hill, New York, pp 687\u2013731"},{"issue":"1","key":"739_CR72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1076\/ocii.6.1.13.8083","volume":"6","author":"WF Shepherd","year":"1998","unstructured":"Shepherd WF, Fsadni MG, Raj PS (1998) A clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgery. Diclofenac-Gentamicin versus Gentamicin Study Group. Ocul Immunol Inflamm 6(1):13\u201318. doi: 10.1076\/ocii.6.1.13.8083","journal-title":"Ocul Immunol Inflamm"},{"issue":"Suppl 1A","key":"739_CR73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(86)90933-2","volume":"80","author":"DC Brater","year":"1986","unstructured":"Brater DC (1986) Drug\u2013drug and drug\u2013disease interactions with nonsteroidal anti-inflammatory drugs. Am J Med 80(Suppl 1A):62\u201377","journal-title":"Am J Med"},{"issue":"1","key":"739_CR74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389450033347064","volume":"4","author":"M Kawase","year":"2003","unstructured":"Kawase M, Motohashi N (2003) New multidrug resistance reversal agents. Curr Drug Targets 4(1):31\u201343. doi: 10.2174\/1389450033347064","journal-title":"Curr Drug Targets"},{"key":"739_CR75","first-page":"24","volume":"30","author":"J Moln\u00e1r","year":"1992","unstructured":"Moln\u00e1r J, F\u00f6lde\u00e1k S, Nakamura MJ, Rausch H, Domonkos K, Szab\u00f3 M (1992) Antiplasmid activity: loss of bacterial resistance to antibiotics. APMIS Suppl 30:24\u201331","journal-title":"APMIS Suppl"},{"issue":"6B","key":"739_CR76","first-page":"5075","volume":"19","author":"N Motohashi","year":"1999","unstructured":"Motohashi N, Kawase M, Saito S, Miskolci C, Berek L, Moln\u00e1r J (1999) Plasmid elimination and immunomodulation by 3-benzazepines in vitro. Anticancer Res 19(6B):5075\u20135078","journal-title":"Anticancer Res"},{"key":"739_CR77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","volume":"31","author":"M Martins","year":"2008","unstructured":"Martins M, Dastidar SG, Fanning S, Kristiansen JE, Moln\u00e1r J, Pag\u00e8s JM, Schelz Z, Spengler G, Viveiros M, Amaral L (2008) Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 31:198\u2013208. doi: 10.1016\/j.ijantimicag.2007.10.025","journal-title":"Int J Antimicrob Agents"},{"key":"739_CR78","doi-asserted-by":"crossref","unstructured":"Dutta NK, Mazumdar K, Park JH (2009) In vitro synergistic effect of gentamicin with the anti-inflammatory agent diclofenac against Listeria monocytogenes. Lett Appl Microbiol. doi: 10.1111\/j.1472-765X.2009.02588.x","DOI":"10.1111\/j.1472-765X.2009.02588.x"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-009-0739-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0739-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T15:08:41Z","timestamp":1633360121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-009-0739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s10096-009-0739-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}